Randomized, Double-Blind Cross-Over Trial Of Buprenorphine and Low-Dose Naloxone Versus Buprenorphine

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00679458
Recruitment Status : Completed
First Posted : May 16, 2008
Last Update Posted : January 7, 2010
Indivior Inc.
Information provided by:
University of California, Los Angeles

Results Submitted - Not Posted on
Results information has been submitted to by the sponsor or investigator, but is not yet publicly available (or "posted") on The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
  Recruitment Status : Completed
  Actual Primary Completion Date : November 2009
  Actual Study Completion Date : November 2009

Submission Cycle Results Submitted to Results Returned after Quality Control Review
1 September 1, 2010 September 24, 2010
2 July 8, 2011 August 2, 2011
3 January 28, 2013 March 4, 2013
4 February 8, 2017 March 28, 2017